Stock Taper Total Revenue: $53.9 million, down 8% year-over-year.
GAAP Net Loss: Improved to $31.7 million from $42.5 million in Q3 2024.
Adjusted EBITDA: Loss of $34 million, an improvement from a loss of $34.8 million last year.
Medicare Segment Revenue: $49.9 million, down from $53.2 million, impacted by lower enrollment volume but partially offset by $12.1 million in positive net adjustment revenue (tail revenue).
Medicare Applications: Decreased by 26%.
Operating Cash Flow: Negative $25.3 million, improved from negative $29.3 million last year.
Cash Position: Ended the quarter with $75.3 million in cash and equivalents.
New CEO Derrick Duke emphasized the company's strong position in the Medicare Advantage market and the importance of the upcoming Annual Enrollment Period (AEP).
Focus on executing AEP effectively, with preparations including a more experienced adviser force and enhanced marketing strategies.
Investments in technology and AI tools, such as the AI screener and MatchMonitor, aimed at improving consumer experience and operational efficiencies.
Continued growth in year-round products like hospital indemnity plans (HIP) and Medicare Supplement (MedSupp), with HIP enrollments more than doubling.
Revenue Guidance for 2025: Expected to be between $525 million and $565 million.
GAAP Net Income Guidance: Raised to a range of $9 million to $30 million, up from $5 million to $26 million.
Adjusted EBITDA Guidance: Increased to $60 million to $80 million, compared to the previous range of $55 million to $75 million.
Operating Cash Flow: Expected to range from negative $25 million to positive $10 million.
Medicare Advantage enrollment volume was below expectations, primarily due to new dual-eligible enrollment rules.
Marketing spend was reduced in Q3 to preserve budget for AEP, indicating potential challenges in consumer acquisition.
The overall Medicare Advantage market is expected to decline by about 3%, which could impact future growth.
Competitive pressures from other brokers and potential share loss if the company does not capitalize on current demand effectively.
Disruption in AEP: Duke noted that while there is a high number of shoppers due to carrier disruptions, the company is seeing similar demand levels as last year, suggesting potential for market share gains.
Opportunistic Marketing: The company plans to be strategic in its marketing investments, focusing on channels with better economics and higher lifetime value to customer acquisition cost (LTV to CAC) ratios.
Retention Strategies: Improved retention rates attributed to brand investments and proactive outreach to members affected by plan changes, with a 20% increase in outbound calls to members.
Commission Rates: Expected to see mid-single-digit percentage increases in commission rates, which will positively impact future LTV metrics. Overall, eHealth is navigating a challenging environment but is positioned to leverage its strengths in technology and customer relationships to drive growth during the critical AEP period.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT